Literature DB >> 27437639

Evaluating the utility of Binax NOW Streptococcus pneumoniae urinary antigen test in adults with community acquired pneumonia in China.

Fei Zhou1,2, Li Gu3, Jiu Xin Qu3, Ying Mei Liu2, Bin Cao1,2.   

Abstract

INTRODUCTION: Binax NOW rapid immunochromatographic membrane test (ICT), a rapid method for detection of Streptococcus pneumoniae antigen, has been used widely in Europe and America, but rarely in China.
OBJECTIVE: Our aim is to evaluate the utility of the ICT among adult patients with community acquired pneumonia (CAP) in China.
METHODS: Adult patients with CAP were prospectively recruited from 12 general hospitals. ICT tests were done in all patients and clinical data were recorded. Qualified sputum culture was used as the standard for determining the diagnostic usefulness of ICT test. RESULT: Thousand hundred fifty four CAP patients were enrolled in analysis, with median (IQR) age of 48 (35) years. 276 (23.9%) patients had underling diseases, 770 (66.7%) had received antibiotics before ICT test. Overall, the positive rate of ICT test was 3.3%, with sensitivity and specificity 57.9% and 96.6%, respectively. Disease severity, chronic obstructive pulmonary disease (COPD), increased age; respiratory rate (RR), neutrophil ratio, blood urea nitrogen (BUN), procalcitonin (PCT) and the decreased oxygenation index were associated with positive results of ICT tests. Patients with BUN >7 mmol/L, CURB-65 3-5, PCT > 2ng/mL were the top three groups with highest positive rate of ICT test (22.6%, 22.2% and 21.1% respectively).
CONCLUSION: ICT test has a moderate sensitivity and high specificity in adults with CAP in China. Patients classified as sever pneumonia, or those with BUN > 7 mmol/L, or PCT > 2 ng/mL are more likely to have positive results.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Streptococcus pneumoniae; adult; community acquired pneumonia; urinary antigen test; utility

Mesh:

Substances:

Year:  2016        PMID: 27437639     DOI: 10.1111/crj.12533

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  7 in total

1.  ARDS Clinical Practice Guideline 2021.

Authors:  Sadatomo Tasaka; Shinichiro Ohshimo; Muneyuki Takeuchi; Hideto Yasuda; Kazuya Ichikado; Kenji Tsushima; Moritoki Egi; Satoru Hashimoto; Nobuaki Shime; Osamu Saito; Shotaro Matsumoto; Eishu Nango; Yohei Okada; Kenichiro Hayashi; Masaaki Sakuraya; Mikio Nakajima; Satoshi Okamori; Shinya Miura; Tatsuma Fukuda; Tadashi Ishihara; Tetsuro Kamo; Tomoaki Yatabe; Yasuhiro Norisue; Yoshitaka Aoki; Yusuke Iizuka; Yutaka Kondo; Chihiro Narita; Daisuke Kawakami; Hiromu Okano; Jun Takeshita; Keisuke Anan; Satoru Robert Okazaki; Shunsuke Taito; Takuya Hayashi; Takuya Mayumi; Takero Terayama; Yoshifumi Kubota; Yoshinobu Abe; Yudai Iwasaki; Yuki Kishihara; Jun Kataoka; Tetsuro Nishimura; Hiroshi Yonekura; Koichi Ando; Takuo Yoshida; Tomoyuki Masuyama; Masamitsu Sanui
Journal:  J Intensive Care       Date:  2022-07-08

2.  Serum Level of 4-Hydroxynonenal in Community-Acquired Pneumonia: A Potential Biomarker for Severity and Prognosis.

Authors:  Ya-Lin Jiang; Hong-Yan Liu; Min-Min Tang; Jia-Yi Cheng; Hui Zhao; Lin Fu
Journal:  Front Med (Lausanne)       Date:  2022-06-17

3.  Pneumococcal and Legionella Urinary Antigen Tests in Community-acquired Pneumonia: Prospective Evaluation of Indications for Testing.

Authors:  Shawna Bellew; Carlos G Grijalva; Derek J Williams; Evan J Anderson; Richard G Wunderink; Yuwei Zhu; Grant W Waterer; Anna M Bramley; Seema Jain; Kathryn M Edwards; Wesley H Self
Journal:  Clin Infect Dis       Date:  2019-05-30       Impact factor: 9.079

4.  Decreased relative risk of pneumococcal pneumonia during the last decade, a nested case-control study.

Authors:  Carlos M Luna; Laura Pulido; Michael S Niederman; Alberto Casey; Diego Burgos; Sebastián D Leiva Agüero; Alejandra Grosso; Evangelina Membriani; Andrea C Entrocassi; Marcelo Rodríquez Fermepin; Carlos A Vay; Susana Garcia; Angela Famiglietti
Journal:  Pneumonia (Nathan)       Date:  2018-09-25

5.  CAPPRIC Study-Characterization of Community-Acquired Pneumonia in Spanish Adults Managed in Primary Care Settings.

Authors:  Jesús Molina; Amelia González-Gamarra; Leovigildo Ginel; Mª Encarnación Peláez; Juan Luis Juez; Antonio Artuñedo; Gonzalo Aldana; Enriqueta Quesada; Joan Josep Cabré; Antonio Gómez; Manuel Linares; Maria Teresa Marín; Pilar Yolanda Sanchez; Leonor Núñez; Jaime Gonzálvez; Enrique Mascarós; Javier López; Agustina Cano; José Herrero; María Carmen Serra; Enrique Cimas; Marta Pedrol; Juan Vicente Alfaro; Federico Martinón-Torres; Isabel Cifuentes; Cristina Méndez; Daniel Ocaña
Journal:  Microorganisms       Date:  2021-02-28

6.  The application value of metagenomic next-generation sequencing in children with invasive pneumococcal disease.

Authors:  Fang Guo; Lei Kang; Meixian Xu
Journal:  Transl Pediatr       Date:  2021-12

7.  Diagnostic accuracy of urinary antigen tests for pneumococcal pneumonia among patients with acute respiratory failure suspected pneumonia: a systematic review and meta-analysis.

Authors:  Shunsuke Yasuo; Maki Murata; Natsuki Nakagawa; Takeshi Kawasaki; Takuo Yoshida; Koichi Ando; Satoshi Okamori; Yohei Okada
Journal:  BMJ Open       Date:  2022-08-11       Impact factor: 3.006

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.